NIH Quantum Sensing Technology Challenge
Awards up to $1.6 million across stages for quantum-enabled biomedical sensing devices.
This is a two-stage federal prize challenge that NCATS runs on behalf of NIH's Qu-BIT program. In Stage 1, competing teams submit a written proposal for adapting an existing quantum-enabled sensing technology to a biomedical or clinical use case, and a panel of subject-matter reviewers scores each submission against published criteria before federal employees make the final selection, subject to s…
The challenge is for multi-disciplinary teams adapting existing quantum-enabled sensing technologies for biomedical research and clinical use, across three areas: general biomedical applications, early detection and diagnostics, and sensing/imaging devices for diagnostics and monitoring. It's one of two parallel prize challenges under NIH's Quantum Biomedical Innovations and Technologies (Qu-BIT) Program.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NCATS
All grants from this funder →Oligonucleotide Toxicity (OligoTox) Open Data Challenge
🇺🇸NCATS · United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
NCATS STTR Phase I
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.
NCATS STTR Phase II
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.
ASPIRE Reduction-to-Practice (Seed)
🇺🇸NCATS · United States
Supports translational chemistry and automation platform development through university-linked partnerships.
Similar grants
Browse the directory →
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge
🇺🇸NIH · United States
Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.
Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge — Track 1
🇺🇸NCI · United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
🇺🇸NIH · United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.
R&D Tax Credit — QSB Payroll Offset (Section 41) — TY2025 / Filed
🇺🇸IRS · United States
Supports United States small businesses through payroll tax offsets when they fund qualifying innovation activity.
Unlocking Urologic Oncology Innovation QuickFire Challenge
🇺🇸J&J Innovation · United States
Supports innovators designing bladder and prostate cancer therapies and surgical tools through a J&J urologic oncology challenge.
DeepTech Frontier Challenge 2026
Global Startup EXPO · Japan
Awards a ¥10 million grand prize to deep-tech startups pitching at Global Startup EXPO 2026.